My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Clearside Biomedical, Inc. - Common Stock (NQ:CLSD)

0.5613 -0.0387 (-6.45%)

Streaming Delayed Price Updated: 4:00 PM EST, Nov 26, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Clearside Biomedical, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >

Top 5 Health Care Stocks That May Crash This Month ↗

January 22, 2024

As of Jan. 22, 2024, five stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.

Via Benzinga

Ocular Gene Therapy: Regenxbio Data Shows Consistent Preservation Of Visual Acuity, Retinal Thickness ↗

January 17, 2024

Regenxbio's latest trial data on ABBV-RGX-314 reveal 80% reduction in injection rate, 50% injection-free, and no intraocular inflammation.

Via Benzinga

Clearside Biomedical: Q3 Earnings Insights ↗

November 13, 2023

Via Benzinga

Over $2M Bet On Community Health Systems? Check Out These 3 Penny Stocks Insiders Are Aggressively Buying ↗

November 02, 2023

The Dow Jones closed higher by over 200 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...

Via Benzinga

Topics Stocks

3 Cheap Stocks to Buy Under $1 in October 2023 ↗

October 26, 2023

If you want extreme returns and can handle the prospects of utterly devastating losses, these cheap stocks under $1 might entice.

Via InvestorPlace

What 8 Analyst Ratings Have To Say About Clearside Biomedical ↗

May 12, 2023

Via Benzinga

Clearside Biomedical: Q1 Earnings Insights ↗

May 11, 2023

Via Benzinga

What 6 Analyst Ratings Have To Say About Clearside Biomedical ↗

April 19, 2023

Via Benzinga

Where Clearside Biomedical Stands With Analysts ↗

April 19, 2023

Via Benzinga

What 5 Analyst Ratings Have To Say About Clearside Biomedical ↗

March 10, 2023

Via Benzinga

Earnings Scheduled For November 13, 2023 ↗

November 13, 2023

Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is expected to report earnings for its third quarter. • Dixie Gr (NASDAQ:DXYN) is estimated to report earnings for its third quarter.

Via Benzinga

Clearside Biomedical's Earnings: A Preview ↗

November 10, 2023

Via Benzinga

Week In Review: QYuns Plans Hong Kong IPO For Autoimmune/Allergic Disease Portfolio ↗

October 07, 2023

Jiangsu QYuns Therapeutics filed for a Hong Kong IPO to underwrite development of its portfolio of clinical stage biologic antibody drugs for autoimmune and allergic diseases. Meanwhile, Biogen...

Via Talk Markets

Topics Initial Public Offering

Clearside Biomedical And 3 Other Stocks Under $3 Insiders Are Buying ↗

October 05, 2023

The Dow Jones closed higher by over 100 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

June 27, 2023

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

May 29, 2023

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

April 04, 2023

Via Benzinga

A Preview Of Clearside Biomedical's Earnings ↗

March 08, 2023

Via Benzinga

Analyst Expectations for Clearside Biomedical's Future ↗

February 03, 2023

Via Benzinga

Analyst Bumps Up Clearside Biomedical Target Price After Encouraging Trial Data ↗

November 10, 2022

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For June 14, 2023 ↗

June 14, 2023

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

March 17, 2023

Via Benzinga

United Airlines To Rally Around 54%? Here Are 10 Other Analyst Forecasts For Friday ↗

March 10, 2023

Piper Sandler raised the price target for Riskified Ltd. (NYSE: RSKD) from $6 to $8. Piper Sandler analyst Brent Bracelin upgraded the stock from Neutral to Overweight. Riskified shares rose 2.4% to...

Via Benzinga

Clearside Biomedical Touts Encouraging Durable Data From Investigational Candidate For Vision Disorder ↗

February 02, 2023

Clearside Biomedical Inc (NASDAQ: CLSD) announced results from the Extension Study of its OASIS Phase 1/2a trial of CLS-AX (axitinib) administered by suprachoroidal injection via SCS Microinjector in...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

January 31, 2023

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

January 17, 2023

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

January 09, 2023

Via Benzinga

AiViva Reports That Their Promising New Treatment For Wet AMD Is Soon To Be Ready For Clinical Trials ↗

November 14, 2022

Visit https://www.startengine.com/aiviva to invest in AiViva’s StartEngine Campaign.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For November 10, 2022 ↗

November 10, 2022

Upgrades

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

November 02, 2022

Gainers Monopar Therapeutics (NASDAQ:MNPR) shares increased by 53.0% to $4.09 during Wednesday's pre-market session. The company's market cap stands at $52.0 million.

Via Benzinga

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.